Cargando…
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
Recent work from our lab and few others have strongly suggested that immunotherapy could be an effective means of preventing the development of tau accumulation in JNPL3 transgenic mice, carrying the human P301L mutation. The aim of this study was to test the efficacy of a variety of specific tau mo...
Autores principales: | d’Abramo, Cristina, Acker, Christopher M., Jimenez, Heidy, Davies, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536019/ https://www.ncbi.nlm.nih.gov/pubmed/26270821 http://dx.doi.org/10.1371/journal.pone.0135774 |
Ejemplares similares
-
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
por: d’Abramo, Cristina, et al.
Publicado: (2013) -
Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
por: Vitale, Francesca, et al.
Publicado: (2018) -
Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice
por: Davidowitz, Eliot J., et al.
Publicado: (2023) -
Gait Ignition Failure in JNPL3 Human Tau-mutant Mice
por: Jang, HoChung, et al.
Publicado: (2019) -
Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo
por: Giliberto, Luca, et al.
Publicado: (2010)